Los Angeles

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Hidradenitis suppurativa2 trials
• Schizophrenia2 trials
• Coeliac disease1 trial

Phase

• Phase 23 trials
• Phase 32 trials

Status

• Completed3 trials
• Enrolling by invitation1 trial
• Recruiting1 trial

Lead sponsor

• MapLight Therapeutics2 trials
• MoonLake Immunotherapeutics AG2 trials
• Provention Bio, a Sanofi Company1 trial

Running trials

• Recruiting

  A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

  NCT07459647· Phase 2· MapLight Therapeutics· Source

• Enrolling by invitation

  A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa

  NCT07007637· Phase 3· MoonLake Immunotherapeutics AG· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Hidradenitis suppurativa1 recruiting
• Schizophrenia1 recruiting

Closed trials

• Completed

  A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia

  NCT07038876· Phase 2· MapLight Therapeutics· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

  NCT06411899· Phase 3· MoonLake Immunotherapeutics AG· Source

• Completed

  PRV-015 in Gluten-free Diet Non-responsive Celiac Disease

  NCT04424927· Phase 2· Provention Bio, a Sanofi Company· Source